DO Generations MAtter for Treatment of Outpatient Pyelonephritis With Cephalosporins in the Emergency Department? DOGMA-ED Study

Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden

10.1016/j.idc.2013.09.003 · 2014

The epidemiology of urinary tract infection

10.1038/nrurol.2010.190 · 2010

US outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011

10.1093/cid/civ076 · 2015

Predicting urinary tract infections in the emergency department with machine learning

10.1371/journal.pone.0194085 · 2018

A call to action for antimicrobial stewardship in the emergency department: approaches and strategies

10.1016/j.annemergmed.2012.09.002 · 2013

The emergency department diagnosis and management of urinary tract infection

10.1016/j.emc.2018.06.003 · 2018

Clinical Practice Guideline by Infectious Diseases Society of America (IDSA): 2025 guideline on management and treatment of complicated urinary tract infections: introduction and methods

10.1093/cid/ciaf459 · 2026

High prevalence of fluoroquinolone-resistant UTI among US emergency department patients diagnosed with urinary tract infection, 2018-2020

10.1111/acem.14545 · 2022

Fluoroquinolone-resistant and extended-spectrum β-lactamase-producing Escherichia coli infections in patients with pyelonephritis, United States

10.3201/eid2209.160148 · 2016

Regional differences in antibiotic-resistant Enterobacterales urine isolates in the United States: 2018-2020

10.1016/j.ijid.2022.03.052 · 2022

Guidelines for the prevention, diagnosis, and management of urinary tract infections in pediatrics and adults: a WikiGuidelines Group Consensus Statement

10.1001/jamanetworkopen.2024.44495 · 2024

International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases

10.1093/cid/ciq257 · 2011

Clinical practice guideline by Infectious Diseases Society of America (IDSA): 2025 guideline on management and treatment of complicated urinary tract infections: selection of antibiotic therapy for complicated UTI

10.1093/cid/ciaf460 · 2026

Cephalosporins for outpatient pyelonephritis in the emergency department: COPY-ED study

10.1016/j.annemergmed.2024.10.013 · 2025

Antibiotic prescribing patterns for adult urinary tract infections within emergency department and urgent care settings

10.1016/j.ajem.2020.09.061 · 2021

Outcomes of high-dose oral beta-lactam definitive therapy compared to fluoroquinolone or trimethoprim-sulfamethoxazole oral therapy for bacteremia secondary to a urinary tract infection

10.1017/ash.2023.435 · 2023

Navigating the muddled middle: a case-based exploration of oral β-lactams for systemic gram-negative infections

10.1093/ofid/ofaf435 · 2025

Oral administration of antibiotics: a rational alternative to the parenteral route

10.1093/clinids/24.3.457 · 1997

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting of observational studies

10.1007/s10049-008-1057-1 · 2008

Urinary tract infections in the emergency department

10.1016/j.idc.2007.10.002 · 2008

Risk factors for aquiring multidrug-resistant organisms in urinary tract infections: a systematic literature review

10.1016/j.jsps.2018.02.023 · 2018

Unresolved referenced work

2020

Unresolved referenced work

2024

Emergency department urinary antibiograms differ by specific patient group

10.1128/jcm.00481-17 · 2017

Unresolved referenced work

2026

Association between urinary community-acquired fluoroquinolone-resistant Escherichia coli and neighbourhood antibiotic consumption: a population-based case-control study

10.1016/s1473-3099(18)30676-5 · 2019

Comparing outcomes among outpatients treated for pyelonephritis with oral cephalosporins versus first-line agents

10.1016/j.ijantimicag.2022.106560 · 2022

A retrospective review of oral cephalosporins versus fluoroquinolones for the treatment of pyelonephritis

2022

Pyelonephritis treatment in the community emergency department: cephalosporins vs. first-line agents

10.1016/j.ajem.2018.08.016 · 2018

Real-world effectiveness of intravenous and oral antibiotic stepdown strategies for gram-negative complicated urinary tract infection with bacteremia

10.1093/ofid/ofae193 · 2024

Oral β-lactams, fluoroquinolones, or trimethoprim-sulfamethoxazole for definitive treatment of uncomplicated Escherichia coli or Klebsiella species bacteremia from a urinary tract source

10.1093/ofid/ofad657 · 2024

Highly versus less bioavailable oral antibiotics in the treatment of gram-negative bloodstream infections: a propensity-matched cohort analysis

10.1016/j.cmi.2022.10.004 · 2023

Oral β-lactam antibiotics vs fluoroquinolones or trimethoprim-sulfamethoxazole for definitive treatment of Enterobacterales bacteremia from a urine source

10.1001/jamanetworkopen.2020.20166 · 2020

Oral β-lactams for complicated urinary tract infections: a systematic review and point-counterpoint comparison with trimethoprim/sulfamethoxazole and fluoroquinolones

10.1002/phar.70118 · 2026

Cefdinir versus cefaclor in the treatment of uncomplicated urinary tract infection

10.1016/s0149-2918(00)80054-5 · 2000

Antibiotics and antibiotic-associated diarrhea: a real-world disproportionality study of the FDA adverse event reporting system from 2004 to 2022

10.1186/s40360-023-00710-w · 2023

Adverse reactions associated with oral and parenteral use of cephalosporins: A retrospective population-based analysis

10.1016/j.jaci.2014.07.062 · 2015